Fiction has been preparing us for an unseen, all knowing CEO for decades. Now technology could make it reality.

Sold under monikers like spice or K2, these gray market synthetics have raised public health alarms for both their toxicity ...

Pfizer faces challenges from pricing pressures, a 2026 patent cliff, and weak R&D momentum. Click here to find out why I rate ...

Construction work paused at 235 East 42nd Street, David Werner and Metro Loft’s massive office-to-resi conversion in Midtown ...

Looking into the current session, Pfizer Inc. (PFE) shares are trading at $25.84, after a 0.39% increase. Moreover, over the ...

Pfizer Inc. advanced stock charts by Barron's. View PFE historical stock data and compare to other stocks, and exchanges.

Contract manufacturers have carved out a lucrative niche within the biopharma industry, and the value of their collective ...

Pfizer’s PFE second-quarter 10% revenue growth and adjusted EPS of $0.78 were ahead of consensus expectations. Management maintained full-year revenue guidance of $61 billion-$64 billion and ...

The trend in the state is consistent with an uptick in several parts of the country, including New York and California.

Pfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of ...

In 53% of cases, PFE stock has experienced a positive one-day return following the announcement of results.

Pfizer exceeds analyst expectations with $0.78 EPS and $14.7B revenue in Q2 2025, beating estimates by significant margins despite recent stock struggles.